| FEBS Letters | |
| Carbamate analogues of (−)‐physostigmine: In vitro inhibition of acetyl‐ and butyrylcholinesterase | |
| Brossi, Arnold2  Yu, Qian-Sheng2  Atack, John R.1  Rapoport, Stanley I.1  | |
| [1] Laboratory of Neurosciences, NIA, National Institutes of Health, Bethesda, MD 20892, USA;Medicinal Chemistry Section, Laboratory of Analytical Chemistry, NIDDK Bethesda, MD 20892, USA | |
| 关键词: Carbamate analogue; Enzyme inhibition; Acetylcholinesterase; Butyrylcholinesterase; | |
| DOI : 10.1016/0014-5793(88)81317-6 | |
| 学科分类:生物化学/生物物理 | |
| 来源: John Wiley & Sons Ltd. | |
PDF
|
|
【 摘 要 】
Reaction of (−)-eseroline (1) with alkyl, aryl and aralkylisocyanates afforded a series of carbamate analogues of (−)-physostigmine (2) which were assayed for inhibition of acetyl- and butyrylcholinesterase (AChE and BChE, respectively) in vitro. Included in this study were two N-alkyl-substituted carbamates 9 and 14 obtained from (−)-eseroline (1) with dialkylcarbamoyl chlorides, and allophanates 12 and 13 obtained as by-products in the reaction of 1 and benzylcarbamoyl eseroline (8) with benzyl isocyanate. Whereas none of the analogues studied was more potent than 2 against electric eel AChE, and carbamates 6, 7 and 8 were all more than 3 times more potent against human plasma BChE than 2.
【 授权许可】
Unknown
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201912020290757ZK.pdf | 330KB |
PDF